Nyhet
The Medical Products Agency approves Immunicum's application to start a clinical phase I/II trial
2011-11-25 14:23The Medical Products Agency approves Immunicum's application to start a clinical phase I/II trial (EudraCT-nr 2011-002039-25) in renal cell carcinoma. The trial is expected to commence in Q1 2012.
Kategorisering
- Ämnen:
- Friskvård,
- Forskning,
- Hälso-, sjukvård,
- Hälsoorganisationer,
- Naturvetenskap,
- Medicin,
- Medicinsk forskning,
- Vetenskapliga institutioner,
- Undersökningar
- Regioner:
- Göteborg
- Tags:
- clinical trials,
- clinical phase i/ii trial,
- renal cell carcinoma,
- immunicum,
- medical products agency
Lägg till kommentarKommentaren sparades
Innan den publiceras måste den godkännas av GöteborgBIO.